DNA helix with highlighted section

Understanding the value of genetic data in clinical practice

Course details


Duration

1 day

Dates
6 November 2017

Fees
£160 Early Bird Rate (available until 31 August 2017)
£180 Full Rate

Upon registration there is the opportunity to request a voucher to purchase a 23andMe test for a discounted price of £99 (+ shipping). Please not that there is a 6-8 week lead time for test results so for bookings made after 8th September 2017 it is unlikely that test results will arrive before the course date.
 

Location
The Wellcome Collection 
Euston Road
London
NW1 2BE

Download programme [pdf]Register and pay
The increase in availability of genetic testing in the clinic presents both new opportunities and new challenges. During this one-day course we aim to equip clinicians with the knowledge of how genomic technologies are changing clinical practice, and the understanding needed to take advantage of this ever-evolving field.
 
This course will provide an introduction to how genetic information can impact patient diagnosis, treatment and management using a range of both common and rare cardiac conditions as illustrations. We will also touch on the ethical and counselling implications of this data. Finally, the course will involve an interactive session allowing delegates to become familiar with direct-to-consumer genetic tests that they may encounter in their practice.
 
After registration, delegates will be offered the opportunity to undergo a Direct to Consumer genetic test (23andMe), to learn more about this and experience the process for themselves. We will discuss the reports generated from these tests and delegates will have the opportunity to interpret their own test results. This is not a requirement and alternative examples will be provided.
 
Please note: For registrations received after 8th September 2017 it is unlikely the test results will arrive before the course start date. 
 
CPD sought from the Royal College of Physicians (6 credits). 

Learning outcomes

Following attendance on this course, delegates will be able to:
  • Identify the role of genetic testing in the diagnosis, pathophysiology and risk stratification of common and rare cardiovascular disorders
  • Discuss the impact of NGS testing on a patient and their family and associated ethical considerations
  • Understand reports generated by direct-to-consumer genetic testing and be able to discuss the content with patients and their families
  • Learn about future directions and novel therapies in genetics of cardiovascular disease

Target audience

This course in suitable for clinicians at any stage of medical training, allied health professionals and researchers with an interest in the growing applications of genomic information in the clinic, and how genomic data can be translated into mainstream clinical practice. Detailed prior knowledge of cardiovascular phenotypes and/or genetics will not be assumed.


Key speakers

  • Professor Stuart Cook (keynote)
  • Dr James Ware
  • Dr Jan Till
  • Dr Sanjay Prasad
  • Dr Tessa Homfray
  • Dr Catherine Francis
  • Dr Nicola Whiffin

Course organiser

Terms and conditions

Terms and conditions

Cancellations must be received in writing one calendar month before each course and will be subject to an administration charge of £50-£150 depending on the course. Cancellations received within a month of the course cannot be accepted and the attendee will be liable for the full course fee. Substitutions may be made at any time.
 
The organiser cannot accept liability for cost incurred in the event of a course having to be cancelled as a result of circumstances beyond its reasonable control.